ACCELERATE DIAGNOSTICS INC (AXDX) Stock Price, Quote, News and Overview
NASDAQ:AXDX - Nasdaq - US00430H2013 - Common Stock - Currency: USD
AXDX Quote, Performance and Key Statistics
0.034
-0.05 (-61.36%)
The current stock price of AXDX is 0.034 USD. In the past month the price decreased by -93.7%. In the past year, price decreased by -96.15%.
AXDX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.83 | 230.75B | ||
| ISRG | INTUITIVE SURGICAL INC | 71.61 | 196.08B | ||
| BSX | BOSTON SCIENTIFIC CORP | 38.76 | 154.77B | ||
| SYK | STRYKER CORP | 30.31 | 144.95B | ||
| MDT | MEDTRONIC PLC | 15.35 | 108.26B | ||
| BDX | BECTON DICKINSON AND CO | 12.29 | 49.72B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.27 | 44.74B | ||
| IDXX | IDEXX LABORATORIES INC | 43.94 | 40.59B | ||
| RMD | RESMED INC | 27.07 | 36.04B | ||
| DXCM | DEXCOM INC | 51.45 | 33.29B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.13 | 31.86B | ||
| STE | STERIS PLC | 26.37 | 24.20B |
Related stock screener links
About AXDX
Company Profile
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. The company is headquartered in Denver, Colorado and currently employs 107 full-time employees. Its Accelerate Pheno system and Accelerate PhenoTest BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the optimal antibiotic therapy for infections. The Accelerate PhenoTest BC Kit, which is the test kit for the system, is indicated as an aid, in conjunction with other clinical and laboratory findings, in the diagnosis of bacteremia and fungemia, both life-threatening conditions with high morbidity and mortality risk. The device provides identification (ID) results followed by antibiotic susceptibility testing (AST) for certain pathogenic bacteria commonly associated with or causing bacteremia. Its other products include Accelerate Pheno system and BC kit, Accelerate Arc system and BC Kit (Accelerate Arc Products), and Accelerate Wave system.
Company Info
ACCELERATE DIAGNOSTICS INC
3950 S Country Club Rd Ste 470 Bldg 3-307
Denver COLORADO 85714 US
CEO: Jack Phillips
Employees: 107
Phone: 13038638088
ACCELERATE DIAGNOSTICS INC / AXDX FAQ
What is the stock price of ACCELERATE DIAGNOSTICS INC today?
The current stock price of AXDX is 0.034 USD. The price decreased by -61.36% in the last trading session.
What is the ticker symbol for ACCELERATE DIAGNOSTICS INC stock?
The exchange symbol of ACCELERATE DIAGNOSTICS INC is AXDX and it is listed on the Nasdaq exchange.
On which exchange is AXDX stock listed?
AXDX stock is listed on the Nasdaq exchange.
What is ACCELERATE DIAGNOSTICS INC worth?
ACCELERATE DIAGNOSTICS INC (AXDX) has a market capitalization of 857.14K USD. This makes AXDX a Nano Cap stock.
How many employees does ACCELERATE DIAGNOSTICS INC have?
ACCELERATE DIAGNOSTICS INC (AXDX) currently has 107 employees.
Is ACCELERATE DIAGNOSTICS INC (AXDX) expected to grow?
The Revenue of ACCELERATE DIAGNOSTICS INC (AXDX) is expected to grow by 3.44% in the next year. Check the estimates tab for more information on the AXDX EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ACCELERATE DIAGNOSTICS INC (AXDX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AXDX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AXDX, evaluating the profitability, health, valuation and growth aspects
- ACCELERATE DIAGNOSTICS INC (AXDX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ACCELERATE DIAGNOSTICS INC (AXDX) Sales and EPS estimates to see what analysts future expectations are.
- ACCELERATE DIAGNOSTICS INC (AXDX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ACCELERATE DIAGNOSTICS INC (AXDX) Insider and Institutional Ownership to learn about the owners and their transactions.
- ACCELERATE DIAGNOSTICS INC (AXDX) Stock Chart to make your own analysis
- ACCELERATE DIAGNOSTICS INC (AXDX) Latest news and press-releases to stay up to date.
Does ACCELERATE DIAGNOSTICS INC (AXDX) stock pay dividends?
AXDX does not pay a dividend.
When does ACCELERATE DIAGNOSTICS INC (AXDX) report earnings?
ACCELERATE DIAGNOSTICS INC (AXDX) will report earnings on 2025-08-06, after the market close.
What is the Price/Earnings (PE) ratio of ACCELERATE DIAGNOSTICS INC (AXDX)?
ACCELERATE DIAGNOSTICS INC (AXDX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.38).
What is the Short Interest ratio of ACCELERATE DIAGNOSTICS INC (AXDX) stock?
The outstanding short interest for ACCELERATE DIAGNOSTICS INC (AXDX) is 1.89% of its float. Check the ownership tab for more information on the AXDX short interest.
AXDX Technical Analysis
AXDX Financial Highlights
Over the last trailing twelve months AXDX reported a non-GAAP Earnings per Share(EPS) of -2.38. The EPS increased by 35.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -175.26% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
AXDX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 86% to AXDX. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 14.29% and a revenue growth 3.44% for AXDX